Cargando…
First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania
Patients with chronic lung conditions, including cystic fibrosis, may be prone to severe COVID-19. Therefore, therapeutic intervention should be prompt and tailored to all associated comorbidities. We report the case of a 17-year-old male adolescent with cystic fibrosis and multiple chronic conditio...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774439/ https://www.ncbi.nlm.nih.gov/pubmed/35054306 http://dx.doi.org/10.3390/diagnostics12010137 |
_version_ | 1784636342359031808 |
---|---|
author | Stan, Iustina Violeta Miron, Victor Daniel Vangheli, Ioana Alexandra Gheorghiu, Radu Marian Streinu-Cercel, Anca Săndulescu, Oana Craiu, Mihai |
author_facet | Stan, Iustina Violeta Miron, Victor Daniel Vangheli, Ioana Alexandra Gheorghiu, Radu Marian Streinu-Cercel, Anca Săndulescu, Oana Craiu, Mihai |
author_sort | Stan, Iustina Violeta |
collection | PubMed |
description | Patients with chronic lung conditions, including cystic fibrosis, may be prone to severe COVID-19. Therefore, therapeutic intervention should be prompt and tailored to all associated comorbidities. We report the case of a 17-year-old male adolescent with cystic fibrosis and multiple chronic conditions (bronchiectasis, exocrine pancreatic insufficiency, chronic multidrug resistant Pseudomonas aeruginosa colonization, nasal polyposis, chronic sinusitis, ventricular extrasystoles and multiple drug allergies), who presented with an acute episode of productive cough, and was confirmed with moderate COVID-19 based on positive RT-PCR for SARS-CoV-2 and lung imaging showing isolated foci of interstitial pneumonia. Intravenous treatment with the monoclonal antibody cocktail casirivimab and imdevimab was administered. The evolution was favorable, with rapid remission of the inflammatory syndrome and gradual decrease of cough, without progression to severe or critical COVID-19, but with complications such as repeated hemoptysis, which was due to the patient’s underlying conditions, and which required close monitoring for timely adjustment of the patient’s chronic treatment. |
format | Online Article Text |
id | pubmed-8774439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87744392022-01-21 First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania Stan, Iustina Violeta Miron, Victor Daniel Vangheli, Ioana Alexandra Gheorghiu, Radu Marian Streinu-Cercel, Anca Săndulescu, Oana Craiu, Mihai Diagnostics (Basel) Case Report Patients with chronic lung conditions, including cystic fibrosis, may be prone to severe COVID-19. Therefore, therapeutic intervention should be prompt and tailored to all associated comorbidities. We report the case of a 17-year-old male adolescent with cystic fibrosis and multiple chronic conditions (bronchiectasis, exocrine pancreatic insufficiency, chronic multidrug resistant Pseudomonas aeruginosa colonization, nasal polyposis, chronic sinusitis, ventricular extrasystoles and multiple drug allergies), who presented with an acute episode of productive cough, and was confirmed with moderate COVID-19 based on positive RT-PCR for SARS-CoV-2 and lung imaging showing isolated foci of interstitial pneumonia. Intravenous treatment with the monoclonal antibody cocktail casirivimab and imdevimab was administered. The evolution was favorable, with rapid remission of the inflammatory syndrome and gradual decrease of cough, without progression to severe or critical COVID-19, but with complications such as repeated hemoptysis, which was due to the patient’s underlying conditions, and which required close monitoring for timely adjustment of the patient’s chronic treatment. MDPI 2022-01-07 /pmc/articles/PMC8774439/ /pubmed/35054306 http://dx.doi.org/10.3390/diagnostics12010137 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Stan, Iustina Violeta Miron, Victor Daniel Vangheli, Ioana Alexandra Gheorghiu, Radu Marian Streinu-Cercel, Anca Săndulescu, Oana Craiu, Mihai First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania |
title | First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania |
title_full | First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania |
title_fullStr | First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania |
title_full_unstemmed | First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania |
title_short | First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania |
title_sort | first case of covid-19 treated with monoclonal anti-spike antibodies in a patient with cystic fibrosis in romania |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774439/ https://www.ncbi.nlm.nih.gov/pubmed/35054306 http://dx.doi.org/10.3390/diagnostics12010137 |
work_keys_str_mv | AT staniustinavioleta firstcaseofcovid19treatedwithmonoclonalantispikeantibodiesinapatientwithcysticfibrosisinromania AT mironvictordaniel firstcaseofcovid19treatedwithmonoclonalantispikeantibodiesinapatientwithcysticfibrosisinromania AT vangheliioanaalexandra firstcaseofcovid19treatedwithmonoclonalantispikeantibodiesinapatientwithcysticfibrosisinromania AT gheorghiuradumarian firstcaseofcovid19treatedwithmonoclonalantispikeantibodiesinapatientwithcysticfibrosisinromania AT streinucercelanca firstcaseofcovid19treatedwithmonoclonalantispikeantibodiesinapatientwithcysticfibrosisinromania AT sandulescuoana firstcaseofcovid19treatedwithmonoclonalantispikeantibodiesinapatientwithcysticfibrosisinromania AT craiumihai firstcaseofcovid19treatedwithmonoclonalantispikeantibodiesinapatientwithcysticfibrosisinromania |